Adoptive γδ T cell therapy controls cytomegalovirus infection in preclinical transplantation models
Abstract γδ T cells show promise for anti-tumoral therapies but have yet to be evaluated to treat infectious diseases. In this preclinical study, we assess a Vδ1 + γδ T cell-based adoptive cell therapy, named Delta One T cells, to treat cytomegalovirus (CMV) infection in high-risk transplant recipie...
Збережено в:
| Автори: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Nature Portfolio
2026-02-01
|
| Серія: | Nature Communications |
| Онлайн доступ: | https://doi.org/10.1038/s41467-026-69538-2 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|